FMP

FMP

Enter

VIGL - Vigil Neuroscience, Inc.

Profile of Vigil Neuroscience, Inc.(VIGL), Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifyi

About

ceo

Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://www.vigilneuro.com

exchange

NASDAQ

Description

Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.

CIK

0001827087

ISIN

US92673K1088

CUSIP

92673K108

Address

1 Broadway

Phone

857 254 4445

Country

US

Employee

69

IPO Date

Jan 7, 2022

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep